ABT Stock Ownership Activity

ABBOTT LABORATORIES 13F holders

4 value investing gurus have made changes to the ABBOTT LABORATORIES (ABT) position according to the gurus' latest SEC quarterly report(s). ABT has been completely sold out by 1 guru(s), the number of ABT shares has been increased by 1, decreased by 2 super investor(s).

Which gurus or hedge funds are buying ABT now?

According to the latest SEC filing(s) ABBOTT LABORATORIES (ABT) has been bought by Eric H. Schoenstein - Jensen Investment Management (added shares +1221.16%).

To see more about who is investing in ABBOTT LABORATORIES (ABT), please go to the ABT ownership page.

2015 Q3 (3 results)
Robert Olstein
+10.69%
+10,880
+0.09%
0.56%
David M. Polen
+3.06%
+214,472
+0.16%
5.32%
Eric H. Schoenstein
-8.49%
-8,031
-0.01%
0.06%
Current price: $125.83 212.85% AVG reported price*: $40.22
2015 Q2 (2 results)
David M. Polen
-2.18%
-155,681
-0.15%
6.65%
Robert Olstein
-11.17%
-14,800
-0.10%
0.60%
Current price: $125.83 156.37% AVG reported price*: $49.08
2015 Q1 (2 results)
David M. Polen
+4.42%
+303,121
+0.27%
6.46%
Eric H. Schoenstein
-0.12%
-200
-0.00%
0.11%
Current price: $125.83 171.60% AVG reported price*: $46.33
2014 Q4 (4 results)
Thomas Russo
-1.28%
-1,103
-0.00%
0.04%
Robert Olstein
-1.65%
-3,000
-0.02%
0.98%
Eric H. Schoenstein
-1.86%
-3,040
-0.00%
0.11%
David M. Polen
-2.16%
-150,980
-0.14%
6.35%
Current price: $125.83 179.49% AVG reported price*: $45.02
2014 Q3 (3 results)
Eric H. Schoenstein
-2.01%
-3,350
-0.00%
0.10%
David M. Polen
-2.88%
-207,572
-0.19%
6.54%
C.T. Fitzpatrick
-100.00%
-785
-0.00%
0.00%
Current price: $125.83 202.55% AVG reported price*: $41.59
2014 Q2 (3 results)
C.T. Fitzpatrick
buy
+785
+0.00%
0.00%
David M. Polen
-4.97%
-200,042
-0.34%
3.41%
Eric H. Schoenstein
-94.95%
-3,135,725
-1.85%
0.10%
Current price: $125.83 207.66% AVG reported price*: $40.90
2014 Q1 (4 results)
Robert Olstein
+1.68%
+3,000
+0.02%
0.96%
Eric H. Schoenstein
+0.57%
+18,715
+0.01%
1.83%
David M. Polen
-0.73%
-55,603
-0.05%
6.32%
Daniel Loeb
-100.00%
-3,250,000
-1.96%
0.00%
Current price: $125.83 226.74% AVG reported price*: $38.51
2013 Q4 (4 results)
Daniel Loeb
buy
+3,250,000
+2.36%
0.00%
Robert Olstein
+23.45%
+31,110
+0.19%
0.90%
David M. Polen
+22.39%
+1,398,291
+1.19%
6.48%
Eric H. Schoenstein
-41.90%
-1,847,299
-1.29%
1.39%
Current price: $125.83 228.28% AVG reported price*: $38.33
2013 Q3 (4 results)
Robert Olstein
+12.40%
+8,480
+0.08%
0.39%
Eric H. Schoenstein
+1.27%
+70,999
+0.04%
2.90%
Thomas Russo
+0.23%
+200
+0.00%
0.03%
David M. Polen
-5.54%
-366,097
-0.28%
4.77%
Current price: $125.83 279.11% AVG reported price*: $33.19
2013 Q2 (4 results)
Thomas Russo
buy
+54,802
+0.04%
0.02%
David M. Polen
buy
+3,371,224
+5.48%
2.80%
Eric H. Schoenstein
buy
+5,581,244
+3.19%
3.19%
Robert Olstein
buy
+81,270
+0.72%
0.45%
Current price: $125.83 260.75% AVG reported price*: $34.88
33 of 130

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.